Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I’ve bought another 500k takes me to 1.5m……..be greedy when others are fearful
That’s pretty hefty
Was the same at Hemogenyx. lots of steady selling then a placement even lower.
teeth kicked.
We’ve got a £3M marketcap to raise from, the dilution would be enormous
Same pattern in AVCT recently massive selling from 130p then 50p placing at 30% discount and that’s a retail favourite!!
Nothing like a bit of insider dealing, we’ll see them in court
Lambo is quite correct in saying Immupharma will not be able to raise any funds via a share issue with SP heading to .5p so it will have to pull a large rabbit out of the hat somehow.
I have emailed Lisa regarding the collapse in the SP today and said it is disgraceful that shareholders are kept in the dark as we lose all our investment.
How is the bid above the SP????
Is it’s a coincidence that yesterday 3 new posters with 0 previous posts come on this board and start trying to ramp it… the very next day the price tanks almost as if they knew something bad was on the way and needed to get out….
In freefall, albeit low volume
Where from here?
Fk £12k.
Can they even raise capital at this level. 0.05 a share?
Dallo
it is likely Landstead so in many ways the sooner they do it and finish ...the more likely an Update will follow to move things on from here ...
Fk.
Capitulation now
Awful after 8 years .
Dealing at .85p
Lambo
For what it is worth the market wants to crush the share price now with no support whatsoever.
Not looking good sadly.
They have put themselves in a very sticky situation now, they can’t use Lanstead imo as even raising £500k via Lanstead at this level would put them over the formal takeover level which as a death spiral finance provider they would not ever do. Any normal placing would clearly imo be at a huge discount as the market for biotech placings is beyond appealing right now and the market knows they need cash asap, but who would take a placing knowing Lanstead can and will dump 16% at any price so even if the placing was at 0.5p Lanstead would still sell its holding as that’s the agreement they are a finance provider. And before a professor Alex starts saying I should be sectioned this is all in my opinion based on price action and the previous 3 years cash burn and Lanstead agreement information
Not a tax expert but i would’ve hoped they’d exhausted any cash flow relief from r&d claims before tapping investors every time!
Moneymule I should say
Moneymore
Immupharma has used part of the £62m losses in obtaining R&D Tax Credit relief but a major element of the losses remain untouched ( strangely I think the unused amount may be nearer £50m , a figure quoted by Alex who appears to know an awful lot about Immupharma..I wonder???)
Dallo
many thanks
so the current tax asset is referring to R&D tax credit , whilst Alex´s c.£50m is somehow related to the accumulated losses
I haven’t checked their accounts but if they had half a brain cell they would’ve sacrificed their losses for immediate R&D tax credit relief so this argument is baseless as it’s a non-starter if they’ve done that
Pokerchips
The figure for accumulated losses forward for possible set off of tax liabilities against future profits are a scary £62m as at the end of June 2023.
If a profitable acquirer was to take over Immupharma and merge its business, it would have a significant tax shield derived from Immupharma's losses forward.
The suggestion that somebody may have mental health problems and needs help I found shocking. In my relatively long life I have known several suicide victims and others with mental health issues. The way to help is NOT some random poster on a bulletin board making a diagnosis.
I was one of four retail investors who attended the AGM in June last year and I reported back to this board.
I raised the question of cash and Tim McC swatted back with 'No we need any' and then talked about tax losses etc After the Q and A I was approached by several Directors all saying that with the US deal in the bag this put IMM in a strong position to get up front payments for a ROTW deal for LUPUS and similarly for CIDP. A few weeks later another Lanstead deal was announced.
We were also told that IMM would be more forthcoming in regularly keeping shareholders up to date. Clearly this has not happened. I have asked the company about cash flow issues and been told that information will be available at the time of publishing the Annual Accounts in late April.
INC in which IMM invested £2.5m of it's money is now worth less than £1m-but look s promising. Tim McC is Chairman ad gave an enthusiastic interview recently, has a substantial shareholding himself with more warrants issued recently. I wonder if he is spreading himself to thin-he is after all CEO of IMM and responsible for driving deals through.
Clearly with 1m shares I still have faith in the fundamentals-but I would like to see more progress and also some statement from the company about cash flow-where I agree. there is room for doubt given the nature of the Lanstead deal.
To return to the mental health issue-I intend to report this post-it has no place here.
GLA
The take up by Directors was low-only Lisa invested.